Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Clinical trial NCT05018416 · COMPLETED

Trial details

NCT number: NCT05018416
Sponsor: Prokidney
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Diseases Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus

Start date: 2021-07-27
Primary completion: 2025-05-20
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.